Symptoms and Diagnosis of ADHD Sample Clauses

Symptoms and Diagnosis of ADHD. Whilst attention deficit hyperactivity disorder (ADHD) remains a controversial condition that continues to receive significant levels of coverage within both the medical and general press it is far from being a “new” condition. In an article in The Lancet over a century ago, Xxxxxx Xxxxx, an English paediatrician, described a condition where patients had “marked inability to concentrate and sustain attention”1. The diagnostic criteria for ADHD are described in the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders2. There are three core symptom domains: inattention, hyperactivity and impulsivity. In order to meet the diagnostic criteria symptoms must be pervasive, persistent and impairing. Whilst the DSM system allows hyperactive/impulsive, inattentive and combined presentations, the International Classification of Diseases –Version 10 (ICD-10) diagnosis of hyperkinetic disorder (HKD), a disease of the, describes a more severe form of ADHD which requires the presence all three symptom domains and higher degrees of pervasiveness and impairment.
AutoNDA by SimpleDocs

Related to Symptoms and Diagnosis of ADHD

  • Diagnosis For a condition to be considered a covered illness or disorder, copies of laboratory tests results, X-rays, or any other report or result of clinical examinations on which the diagnosis was based, are required as part of the positive diagnosis by a physician.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Corrective Measures If the Participating Generator fails to meet or maintain the requirements set forth in this Agreement and/or the CAISO Tariff, the CAISO shall be permitted to take any of the measures, contained or referenced in the CAISO Tariff, which the CAISO deems to be necessary to correct the situation.

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Particular Methods of Procurement of Goods Works and Services (other than Consultants’ Services)

  • Particular Methods of Procurement of Goods and Works International Competitive Bidding. Goods and works shall be procured under contracts awarded on the basis of International Competitive Bidding.

  • CORRECTIVE MEASURE The contractor shall repair any deficiencies in excess of the performance guideline.

  • Rhytidectomy Scar revision, regardless of symptoms. • Sclerotherapy for spider veins. • Skin tag removal. • Subcutaneous injection of filling material. • Suction assisted Lipectomy. • Tattooing or tattoo removal except tattooing of the nipple/areola related to a mastectomy. • Treatment of vitiligo. • Standby services of an assistant surgeon or anesthesiologist. • Orthodontic services related to orthognathic surgery. • Cosmetic procedures when performed primarily: o to refine or reshape body structures or dental structures that are not functionally impaired; o to improve appearance or self-esteem; or o for other psychological, psychiatric or emotional reasons. • Drugs, biological products, hospital charges, pathology, radiology fees and charges for surgeons, assistant surgeons, attending physicians and any other incidental services, which are related to cosmetic surgery.

  • Non-Grievability No dispute over a claim for any benefits extended by this Health and Welfare Fund shall be subject to the grievance procedure.

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

Time is Money Join Law Insider Premium to draft better contracts faster.